Unlike most summers when just about every investment banker on Wall Street goes on vacation for the month of July, it appears this year most of them stayed home as the Greek debt crisis slowly unfolded. Combined with China’s collapsing stock market (down 30% in less than a month!), the… Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
As the PIGS go up in smoke, it may soon be time to strike a match in these five countries. Read More
EMC Corp. (NYSE: EMC), whose storage solutions already help to alleviate this data glut, has been innovating and integrating new technologies in order to secure its position as the largest data storage provider in the world. Read More
EMC Corp. (NYSE: EMC), whose storage solutions already help to alleviate this data glut, has been innovating and integrating new technologies in order to secure its position as the largest data storage provider in the world. Read More
If it doesn’t pass Buffett’s five-year rule, maybe a change is in order. Read More
[from the 7/7/2015 edition of Smart Tech 50 Weekly Movers]Although we do not advocate trading the stock market on a short term basis (which we define as a holding period of less than one year), sometimes our model is so accurate in predicting the near term direction of… Read More
[from the 7/7/2015 edition of Smart Tech 50 Weekly Movers]Although we do not advocate trading the stock market on a short term basis (which we define as a holding period of less than one year), sometimes our model is so accurate in predicting the near term direction of… Read More
Turmoil surrounding the Greek debt crisis has brought one of our favorite stocks back down to an attractive level, so we are once again adding it our Investments Portfolio. Read More
Turmoil surrounding the Greek debt crisis has brought one of our favorite stocks back down to an attractive level, so we are once again adding it our Investments Portfolio. Read More
For the reasons described in the 6/29/2015 edition of Smart Tech 50 Weekly Movers, we are adding Meridian Biosciences (VIVO) to the Medical Profits portfolio with a buy limit price of $19 and a stop loss at $16. Read More